Skip to main content
Erschienen in: Cancer Causes & Control 4/2008

01.05.2008 | Original Paper

Cigarette smoking and risk of epithelial ovarian cancer

verfasst von: Mary Anne Rossing, Kara L. Cushing-Haugen, Kristine G. Wicklund, Noel S. Weiss

Erschienen in: Cancer Causes & Control | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

An increased risk of mucinous ovarian tumors among cigarette smokers has been observed in multiple studies. The association of smoking with other histologic types of ovarian cancer is less clear, but potentially holds greater importance for prevention of disease incidence and mortality.

Methods

In a population-based study of 812 women with ovarian cancer diagnosed in western Washington State from 2002–2005 and 1,313 controls, we assessed the risk associated with cigarette smoking, with a particular focus on tumor subgroups jointly classified according to the degree of invasiveness and histology. Information was collected through in-person interviews, and logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs).

Results

The incidence of both borderline and invasive mucinous ovarian tumors was increased among women with a history of cigarette smoking (ORs and 95% CIs = 1.8, 1.2–2.9, and 1.8, 0.8–4.3, respectively). Increases in risk of these tumor types were most evident among women with greater smoking duration and pack-years of exposure, and among those who had smoked within the prior 15 years. We noted no clear patterns of risk of serous tumors with duration or pack-years of smoking; however, risk of these tumor types was somewhat elevated among women who had smoked within the previous 15 years (for borderline serous tumors, OR and 95% CI = 1.5, 0.9–2.3; for invasive serous tumors, OR and 95% CI = 1.4, 1.1–1.9). The risk of endometrioid, clear cell, and the remaining histologic types of invasive ovarian cancer was not increased among smokers.

Conclusion

In the aggregate, evidence is insufficient to determine whether smoking is linked with risk of serous or other non-mucinous histologic types of ovarian cancer. Studies that employ additional histopathologic and molecular techniques to more accurately delineate subsets of tumors may improve our understanding of the impact of smoking on ovarian cancer risk.
Literatur
1.
Zurück zum Zitat Jordan SJ, Whiteman DC, Purdie DM, Green AC, Webb PM. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 2006;103:1122–9.PubMedCrossRef Jordan SJ, Whiteman DC, Purdie DM, Green AC, Webb PM. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 2006;103:1122–9.PubMedCrossRef
2.
Zurück zum Zitat Marchbanks PA, Wilson H, Bastos E, Cramer DW, Schildkraut JM, Peterson HB. Cigarette smoking and epithelial ovarian cancer by histologic type. Obstet Gynecol 2000;95:255–60.PubMedCrossRef Marchbanks PA, Wilson H, Bastos E, Cramer DW, Schildkraut JM, Peterson HB. Cigarette smoking and epithelial ovarian cancer by histologic type. Obstet Gynecol 2000;95:255–60.PubMedCrossRef
3.
Zurück zum Zitat Kuper H, Titus-Ernstoff L, Harlow BL, Cramer DW. Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 2000;88:313–8.PubMedCrossRef Kuper H, Titus-Ernstoff L, Harlow BL, Cramer DW. Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 2000;88:313–8.PubMedCrossRef
4.
Zurück zum Zitat Green A, Purdie D, Bain C, Siskind V, Webb PM. Cigarette smoking and risk of epithelial ovarian cancer (Australia). Cancer Causes Control 2001;12:713–9.PubMedCrossRef Green A, Purdie D, Bain C, Siskind V, Webb PM. Cigarette smoking and risk of epithelial ovarian cancer (Australia). Cancer Causes Control 2001;12:713–9.PubMedCrossRef
5.
Zurück zum Zitat Riman T, Dickman PW, Nilsson S, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case–control study. Gynecol Oncol 2001;83:575–85.PubMedCrossRef Riman T, Dickman PW, Nilsson S, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case–control study. Gynecol Oncol 2001;83:575–85.PubMedCrossRef
6.
Zurück zum Zitat Modugno F, Ness RB, Cottreau CM. Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer. Epidemiology 2001;13:467–71.PubMedCrossRef Modugno F, Ness RB, Cottreau CM. Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer. Epidemiology 2001;13:467–71.PubMedCrossRef
7.
Zurück zum Zitat Goodman MT, Tung KH. Active and passive tobacco smoking and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control 2003;14:569–77.PubMedCrossRef Goodman MT, Tung KH. Active and passive tobacco smoking and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control 2003;14:569–77.PubMedCrossRef
8.
Zurück zum Zitat Terry PD, Miller AB, Jones JG, Rohan TE. Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study. Eur J Cancer 2003;39:1157–64.PubMedCrossRef Terry PD, Miller AB, Jones JG, Rohan TE. Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study. Eur J Cancer 2003;39:1157–64.PubMedCrossRef
9.
Zurück zum Zitat Pan SY, Ugnat AM, Mao Y, Wen SW, Johnson KC. Association of cigarette smoking with the risk of ovarian cancer. Int J Cancer 2004;111:124–30.PubMedCrossRef Pan SY, Ugnat AM, Mao Y, Wen SW, Johnson KC. Association of cigarette smoking with the risk of ovarian cancer. Int J Cancer 2004;111:124–30.PubMedCrossRef
10.
Zurück zum Zitat Riman T, Dickman PW, Nilsson S, Nordlinder H, Magnusson CM, Persson IR. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol 2004;19:1011–9.PubMedCrossRef Riman T, Dickman PW, Nilsson S, Nordlinder H, Magnusson CM, Persson IR. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol 2004;19:1011–9.PubMedCrossRef
11.
Zurück zum Zitat Kurian AW, Balise RR, McGuire V, Whittemore AS. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 2005;96:520–30.PubMedCrossRef Kurian AW, Balise RR, McGuire V, Whittemore AS. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 2005;96:520–30.PubMedCrossRef
12.
Zurück zum Zitat Huusom LD, Frederiksen K, Hogdall EV, et al. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case–control study. Cancer Causes Control 2006;17:821–9.PubMedCrossRef Huusom LD, Frederiksen K, Hogdall EV, et al. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case–control study. Cancer Causes Control 2006;17:821–9.PubMedCrossRef
13.
Zurück zum Zitat Soegaard M, Jensen A, Hogdall E, et al. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev 2007;16:1160–6.PubMedCrossRef Soegaard M, Jensen A, Hogdall E, et al. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev 2007;16:1160–6.PubMedCrossRef
14.
Zurück zum Zitat Gram IT, Braaten T, Adami HO, Lund E, Weiderpass E. Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer. Int J Cancer 2007;122:647–52.CrossRef Gram IT, Braaten T, Adami HO, Lund E, Weiderpass E. Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer. Int J Cancer 2007;122:647–52.CrossRef
15.
Zurück zum Zitat Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007;in press. Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007;in press.
16.
Zurück zum Zitat Fritz AG, Percy C, Andrew J, et al. International classification of diseases for oncology ICD-O, 3rd ed. Geneva: World Health Organization; 2000. Fritz AG, Percy C, Andrew J, et al. International classification of diseases for oncology ICD-O, 3rd ed. Geneva: World Health Organization; 2000.
17.
Zurück zum Zitat Tavassolu FA, Devilee P. World Health Organization classification of tumors. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press; 2003. Tavassolu FA, Devilee P. World Health Organization classification of tumors. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press; 2003.
18.
Zurück zum Zitat Waksberg J. Random digit dialing sampling for case–control studies. In: Gail MH, Benichou J, editors. Encyclopedia of epidemiologic methods. New York: Wiley; 2000. pp. 749–53. Waksberg J. Random digit dialing sampling for case–control studies. In: Gail MH, Benichou J, editors. Encyclopedia of epidemiologic methods. New York: Wiley; 2000. pp. 749–53.
19.
Zurück zum Zitat Scott M, McCluggage WG. Current concepts in ovarian epithelial tumorigenesis: correlation between morphological and molecular data. Histol Histopathol 2006;21:81–92.PubMed Scott M, McCluggage WG. Current concepts in ovarian epithelial tumorigenesis: correlation between morphological and molecular data. Histol Histopathol 2006;21:81–92.PubMed
20.
Zurück zum Zitat Jordan S, Green A, Webb P. Benign epithelial ovarian tumors-cancer precursors or markers for ovarian cancer risk? Cancer Causes Control 2006;17:623–32.PubMedCrossRef Jordan S, Green A, Webb P. Benign epithelial ovarian tumors-cancer precursors or markers for ovarian cancer risk? Cancer Causes Control 2006;17:623–32.PubMedCrossRef
21.
Zurück zum Zitat Voigt LF, Koepsell TD, Daling JR. Characteristics of telephone survey respondents according to willingness to participate. Am J Epidemiol 2003;157:66–73.PubMedCrossRef Voigt LF, Koepsell TD, Daling JR. Characteristics of telephone survey respondents according to willingness to participate. Am J Epidemiol 2003;157:66–73.PubMedCrossRef
22.
Zurück zum Zitat Kjaerbye-Thygesen A, Frederiksen K, Hogdall EV, et al. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2006;15:798–803.PubMedCrossRef Kjaerbye-Thygesen A, Frederiksen K, Hogdall EV, et al. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2006;15:798–803.PubMedCrossRef
23.
Zurück zum Zitat Nagle CM, Bain CJ, Webb PM. Cigarette smoking and survival after ovarian cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2006;15:2557–60.PubMedCrossRef Nagle CM, Bain CJ, Webb PM. Cigarette smoking and survival after ovarian cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2006;15:2557–60.PubMedCrossRef
24.
Zurück zum Zitat Piek JM, Kenemans P, Zweemer RP, van Diest PJ, Verheijen RH. Ovarian carcinogenesis, an alternative theory. Gynecol Oncol 2007;107:355.PubMedCrossRef Piek JM, Kenemans P, Zweemer RP, van Diest PJ, Verheijen RH. Ovarian carcinogenesis, an alternative theory. Gynecol Oncol 2007;107:355.PubMedCrossRef
25.
Zurück zum Zitat Russell SE, McCluggage WG. A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes. J Pathol 2004;203:617–9.PubMedCrossRef Russell SE, McCluggage WG. A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes. J Pathol 2004;203:617–9.PubMedCrossRef
Metadaten
Titel
Cigarette smoking and risk of epithelial ovarian cancer
verfasst von
Mary Anne Rossing
Kara L. Cushing-Haugen
Kristine G. Wicklund
Noel S. Weiss
Publikationsdatum
01.05.2008
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 4/2008
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-007-9103-8

Weitere Artikel der Ausgabe 4/2008

Cancer Causes & Control 4/2008 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.